BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33164398)

  • 1. [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].
    Jiang-Dong D; Chuan-Yan L; Bing Y; Yue W; Li C; Liang F; Xiao-Bin J
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4140-4148. PubMed ID: 33164398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
    Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
    Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on hepatoprotective mechanisms of Veratrilla baillonii based on network pharmacology].
    He CJ; Wang J; Liang S; Li J; Huang XJ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1789-1799. PubMed ID: 32489062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Multi-component-multi-target-multi-pathway" mechanism of Kuihua Hugan Tablets based on network pharmacology].
    Shen HB; Zhou YN; Zheng J; Zhu RH
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1464-1474. PubMed ID: 31090306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Material basis and mechanism of Xiao'er Resuqing Oral Liquid on hand, foot and mouth disease based on network pharmacology and molecular docking].
    Xu YL; Guo SS; Cui XL; Shi YJ
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5745-5752. PubMed ID: 33496115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease.
    Zhang M; Yuan Y; Zhou W; Qin Y; Xu K; Men J; Lin M
    Comput Biol Chem; 2020 Jun; 86():107248. PubMed ID: 32208163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the mechanism of
    Liao Y; Ding Y; Yu L; Xiang C; Yang M
    Front Pharmacol; 2022; 13():1027112. PubMed ID: 36457705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
    Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
    Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration on mechanisms of Xiaoyao Powder in treating atherosclerosis and depressive disorder with concept of "treating different diseases with same method" based on network pharmacology].
    Ming-Tai C; Jiao X; Hai-Dan L; Ying LI; Mei-Huan LI; Jie-Nan L; Zhong Z
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4099-4111. PubMed ID: 33164394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of volatile oil from Alpinia oxyphylla in treating Alzheimer's disease based on GC-MS and network pharmacology].
    Li WJ; Xiao S; Zheng Q; Zhu LY; Zhang MX; Yang M; Yan Y; Wang ZY
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):3052-3057. PubMed ID: 34467695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of Shengjiang Powder in treating chronic tonsillitis in children based on network pharmacology and molecular docking].
    He HA; Wang X; Chen YT; Song Z; Zhang BQ
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):877-884. PubMed ID: 33645092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective mechanism of
    Jiang G; Sun C; Wang X; Mei J; Li C; Zhan H; Liao Y; Zhu Y; Mao J
    Bioengineered; 2022 Mar; 13(3):5216-5235. PubMed ID: 35170400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on mechanism of combination of Platycodonis Radix and Lilii Bulbus with homology of medicine and food in treating pneumonia].
    Deng YL; Ye XW; Liu MM; Liu Y; Wan Q; Huang M; Xie YT; Zhang T; Liu HP; Zhang ZW; Zhang JL
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2403-2412. PubMed ID: 34047084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
    Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of Spatholobi Caulis in treatment of ovarian cancer based on network pharmacology and experimental verification].
    Zhu SC; Cai J; Wu CY; Cheng CS
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):786-795. PubMed ID: 35178962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of Linderae Radix against gastric cancer based on network pharmacology and in vitro experimental validation].
    Liang X; Zhang JH; Bai HT; Li YL; Sun SH; Zhang QQ; Yang J; Wang R
    Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(18):5008-5021. PubMed ID: 36164911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
    Yang H; Wei D; Zhang Y; Jian W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.